ET-1 in the myocardial interstitium: Relation to myocyte ECE activity and expression

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 6 47-6, 2000, Pages

  Ergul, Adviye ^a   Walker, C Allyson ^a   Goldberg, Aron ^a   Baicu, Simona C ^a   Hendrick, Jennifer W ^a   King, Mary K ^a   Spinale, Francis G ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Congestive heart failure; Endothelin 1; Endothelin converting enzyme; Interstitial fluid

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; SWINE;

EID: 0033939027     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.6.h2050     Document Type: Article

References (36)

1. Azevedo ER, Stewart DJ, and Parker JD. Increased cardiac extraction of endothelin by the failing human heart (Abstract). Circulation 98: 1-24, 1998.
2. Battistini B and Dussault P. Blocking of the endothelin system: the development of receptor antagonists. Pulm Pharmacol 11: 97-112, 1998.
3. Bozkurt B, Kribbs SB, Clubb FJJ, Michael LH, Didenko W, Hornsby PJ, Seta Y, Oral H, Spinale FG, and Mann DL. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97: 1382-1391, 1998.
4. Dell'Italia LJ, Meng QC, Balcells E, Wei C, Palmer R, Hageman GR, Durand J, Hankes GH, and Oparil S. Compartmentalization of angiotensin II generation in the dog heart. J Clin Invest 100: 253-258, 1997.
5. Dibbs Z, White BG, and Mann DL. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol 33: 1935-1942, 1999.
6. Dupuis J, Stewart DJ, Cernacek P, and Gosselin G. Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 94: 1578-1584, 1996.
7. Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, and Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 199: 1461-1465, 1994.
8. Jones LG, Rozich JD, Tsutsi H, and Cooper G. Endothelin stimulates multiple responses in isolated adult ventricular myocytes. Am J Physiol Heart Circ Physiol 263: H1447-H1454, 1992.
9. Kimura S, Kasuya Y, Sawamura T, Shinmi O, Sugita Y, Yanagisawa M, Goto K, and Masaki T. Conversion of big endothelin-1 to 21-residue endothelin-1 is essential for expression of full vasoconstrictor activity: structure-activity relationships of big endothelin-1. J Cardiovasc Pharmacol 13: S5-S7, 1989.
10. Kiowski W, Sutsch G, Hunziker P, Muller P, Kim J, Oechslin E, Schmitt R, Jones R, and Bertel O. Evidence of endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 346: 732-736, 1995.
11. 1 receptor inhibition, and combination therapy with pacinginduced heart failure: effects on left ventricular performance and regional blood flow patterns. Cardiovasc Res 38: 631-645, 1997.
12. Margulies KB, Hildebrant JFL, Lerman A, Perrella MA, and Burnett JC Jr. Increased endothelin in experimental heart failure. Circulation 82: 2226-2230, 1990.
13. Marriott JB, Goldman JH, Keeling PJ, Baig MK, Dalgleish AG, and McKenna WJ. Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives. Heart 75, 287-290, 1996.
14. Masaki T. Effect of endothelin on circulation system. In: Vascular Innervation and Receptor Mechanism, New Perspective, edited by Edvinsson L and Uddman R. San Diego: Academic Press, 1993, p. 87-105.
15. Miller WL, Redfield MN, and Burnett JC Jr. Integrated cardiac, renal, and endocrine response to intravenous endothelin in conscious dogs. J Clin Invest 83: 317-320, 1989.
16. Miyauchi T and Masaki T. Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 61: 391-415, 1999.
17. Munger MA, Johnson M, Amber IJ, Callahan KS, and Gilbert EM. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or dilated cardiomyopathy. Am J Cardiol 77: 723-727, 1996.
18. Onishi K, Ohno M, Little WC, and Cheng CP. Endogenous endothelin-1 depresses left ventricular systolic and diastolic performance in congestive heart failure. J Pharmacol Exp Ther 288: 1214-1222, 1999.
19. Pacher R, Stanek B, and Hulsmann M. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. Am J Cardiol 27: 633-641, 1996.
20. Parker JD, Theissen TJ, Reilly R, Tong TH, Stewart DJ, and Pandey AS. Human endothelin-1 clearance kinetics revealed by a radiotracer technique. J Pharmacol Exp Ther 289: 261-265, 1999.
21. Rubanyi GM and Polokoff MA. . Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46: 325-415, 1994.
22. Shimada K, Takahashi M, Ikeda M, and Tanzawa K. Identification and characterization of two isoforms of an endothelin converting enzyme-1. FEBS Lett 371: 140-144, 1995.
23. Spinale FG, Walker JD, Mukherjee R, Iannini JP, Keever AT, and Gallagher KP. Concomitant endothelin receptor subtype-A blockade during progression of pacing-induced congestive heart failure in rabbits. Circulation 95: 1918-1929, 1997.
24. Stanek B, Frey B, Berger R, Hartter E, and Pacher P. Value of sequential big endothelin plasma concentrations to predict rapid worsening of chronic heart failure. Transplant Proc 31: 155-157, 1999.
25. Stewart DJ, Cernacek P, Costello KB, and Rouleau JL. Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation 85: 510-517, 1992.
26. Suzuki M, Ohte N, Wang ZM, Williams DLJ, Little WC, and Cheng CP. Altered inotropic response to endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy. Cardiovasc Res 39: 589-599, 1998.
27. Thomas PB, Liu ECK, Webb ML, Mukherjee R, and Spinale FG. Evidence of the endothelin-1 autocrine loop in cardiac myocytes: relation to contractile function congestive heart failure. Am J Physiol Heart Circ Physiol 271: H2629-H2637, 1996.
28. Turner AJ, Barnes K, Schweizer A, and Valdenaire O. Isoforms of endothelin converting enzyme: why and where? Trends Pharmacol Sci 19: 483-486, 1998.
29. Valdenaire O, Rohrbacher E, and Mattei M-G. Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J Biol Chem 270: 29794-29798, 1995.
30. Webb ML and Meek TD. Inhibitors of endothelin. Med Res Rev 17: 17-67, 1997.
31. Wei C-C, Meng QC, Palmer R, Hageman GR, Durand J, Bradley WE, Farrell DM, Hankes GH, Oparil S, and Dell'Italia LJ. Evidence for angiotensin converting enzyme-and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo. Circulation 99: 2583-2589, 1999.
32. Wei CM, Lerman A, Rodeheffer RJ, McGregor CGA, Brandt RR, Wright S, Heublein DM, Kao PC, Edwards WD, and Burnett JC Jr. Endothelin in human congestive heart failure. Circulation 89: 1580-1586, 1994.
33. Woods M, Mitchell JA, Wood EG, Barker S, Walcot NR, Rees GM, and Warner TD. Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: evidence for intracellular converting enzyme. Mol Pharmacol 55: 902-909, 1999.
34. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, and Yanagisawa M. A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78: 473-485, 1994.
35. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
36. Zolk O, Quattek J, Sitzler G, Schrader T, Nickenig G, Schnabel P, Shimada K, Takahashi M, and Bohm M. Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure. Circulation 99: 2118-212, 1999.